Zeleke, Tizita Z.
Pan, Qingfei
Chiuzan, Codruta http://orcid.org/0000-0001-8169-5032
Onishi, Maika
Li, Yuxin http://orcid.org/0000-0001-9739-9860
Tan, Haiyan
Alvarez, Mariano J.
Honan, Erin
Yang, Min
Chia, Pei Ling
Mukhopadhyay, Partha
Kelly, Sean
Wu, Ruby
Fenn, Kathleen
Trivedi, Meghna S.
Accordino, Melissa http://orcid.org/0000-0002-4156-7279
Crew, Katherine D.
Hershman, Dawn L.
Maurer, Matthew
Jones, Simon
High, Anthony
Peng, Junmin http://orcid.org/0000-0003-0472-7648
Califano, Andrea http://orcid.org/0000-0003-4742-3679
Kalinsky, Kevin http://orcid.org/0000-0002-3113-7902
Yu, Jiyang http://orcid.org/0000-0003-3629-4330
Silva, Jose http://orcid.org/0000-0001-5147-8950
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA153233, CA217858, S10 OD012351, S10 OD021764, CA153233)
The Irving Scholar Program
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM134382)
American Lebanese Syrian Associated Charities
U.S. Department of Defense (151500)
Article History
Received: 22 December 2020
Accepted: 10 November 2022
First Online: 30 December 2022
Competing interests
: M.Y. and S.J. were Acetylon employees when this project was initiated. This research has been partially supported by a sponsor research agreement with Acetylon. J.Y. was a consultant of the computational analysis for the phase 1b trial 2015–2017. M.J.A. is Chief Scientific Officer and equity holder at DarwinHealth, a company that has licensed some of the algorithms used in this paper from Columbia University. A.C. is the founder, equity holder, consultant and director of DarwinHealth, a company that has licensed some of the algorithms used in this paper from Columbia University. Columbia University is also an equity holder in DarwinHealth. The remaining authors declare no competing interests.